Plum J, Schoenicke G, Grabensee B
Department of Nephrology and Rheumatology, Heinrich-Heine University Dusseldorf, Germany.
Am J Kidney Dis. 1997 Sep;30(3):413-22. doi: 10.1016/s0272-6386(97)90287-0.
Peritonitis remains a major problem in peritoneal dialysis. The incidence of peritonitis may be reduced by the use of more "biocompatible" peritoneal dialysis solutions that do not impair local host defense mechanisms, such as occurs with conventional lactate-buffered glucose solutions. In the present study, we investigated the use of bicarbonate and lactate as buffer systems and glucose, amino acids, and glucose polymer as osmotic agents on specific cellular functions of isolated fresh blood monocytes in vitro. The bicarbonate-buffered solutions had a physiologic pH (7.0 to 7.6). Lactate-buffered solutions were tested with a pH between 5.5 and 7.3. RPMI 1640 (Roswell Park Memorial Institute, supplied by Biochrom, Berlin, Germany) and phosphate-buffered saline were used as control mediums. The test solutions were incubated with 200,000 monocytes/mL for 45 minutes followed by a 1:1 mix with RPMI 1640 (with supplements) during a 24- or 4-hour tetrazolium bromide test (MTT test) recovery period. Constitutive and lipopolysaccharide (LPS)-stimulated release of interleukin-1beta (IL-1beta) and IL-6 in the supernatants as parameters of cellular host defense and lactate dehydrogenase concentrations and MTT-formazan production as parameters for cell cytotoxicity were measured. Significantly higher IL-6 and IL-1beta release was found in the bicarbonate-buffered solutions, both under basal conditions and after LPS stimulation, compared with the lactate-buffered solutions (LPS stimulation: 1% amino acids/34 mmol/L bicarbonate, IL-1beta: 1,166 +/- 192 pg/mL; 1.5% glucose/34 mmol/L bicarbonate, IL-1beta: 752 +/- 107 pg/mL; 1.5% glucose/35 mmol/L lactate/pH 5.5, IL-1beta: 174 +/- 51 pg/mL). Some of these differences could even be detected in spent dialysate after a 6-hour dwell in continuous ambulatory peritoneal dialysis patients (n = 10). A lower degree of cellular cytotoxicity (lactate dehydrogenase activity) and better-preserved metabolic activity (MTT test) also were found for the bicarbonate-buffered solutions. Amino acids (1%) proved to be comparable to glucose (1.5%) as an osmotic agent at a neutral pH with regard to LPS-stimulated cytokine release and cytotoxicity. The incubation with a glucose polymer solution (7.5% glucose polymer in phosphate-buffered saline, pH 7.3) resulted in a significantly lowered cytokine release (LPS stimulation: IL-1beta, 69 +/- 19 pg/mL) compared with the other solutions with neutral pH (P < 0.01). These results suggest that bicarbonate as a buffer provided better biocompatibility with regard to mononuclear cytokine release and viability compared with lactate. Amino acids and glucose were equivalent to these parameters at a physiologic pH. The glucose polymer solution, however, was associated with a marked depression of cytokine release.
腹膜炎仍然是腹膜透析中的一个主要问题。使用更具“生物相容性”的腹膜透析液可降低腹膜炎的发生率,这类透析液不会损害局部宿主防御机制,而传统的乳酸缓冲葡萄糖溶液则会出现这种情况。在本研究中,我们体外研究了以碳酸氢盐和乳酸作为缓冲系统,以及以葡萄糖、氨基酸和葡萄糖聚合物作为渗透剂对分离出的新鲜血液单核细胞特定细胞功能的影响。碳酸氢盐缓冲溶液具有生理pH值(7.0至7.6)。测试的乳酸缓冲溶液的pH值在5.5至7.3之间。RPMI 1640(罗斯韦尔公园纪念研究所,由德国柏林的Biochrom公司提供)和磷酸盐缓冲盐水用作对照培养基。将测试溶液与每毫升200,000个单核细胞孵育45分钟,随后在24小时或4小时的溴化四氮唑蓝试验(MTT试验)恢复期与RPMI 1640(含补充剂)按1:1混合。测量上清液中白细胞介素-1β(IL-1β)和IL-6的组成性释放以及脂多糖(LPS)刺激后的释放,以此作为细胞宿主防御的参数,同时测量乳酸脱氢酶浓度和MTT-甲臜产物,以此作为细胞毒性的参数。与乳酸缓冲溶液相比,在基础条件下和LPS刺激后,碳酸氢盐缓冲溶液中均发现IL-6和IL-1β的释放显著更高(LPS刺激:1%氨基酸/34 mmol/L碳酸氢盐,IL-1β:1,166±192 pg/mL;1.5%葡萄糖/34 mmol/L碳酸氢盐,IL-1β:752±107 pg/mL;1.5%葡萄糖/35 mmol/L乳酸/pH 5.5,IL-1β:174±51 pg/mL)。在持续非卧床腹膜透析患者(n = 10)进行6小时留腹后的用过的透析液中甚至也能检测到其中一些差异。对于碳酸氢盐缓冲溶液,还发现细胞毒性程度较低(乳酸脱氢酶活性)且代谢活性保存较好(MTT试验)。就LPS刺激的细胞因子释放和细胞毒性而言,在中性pH条件下,氨基酸(1%)被证明作为渗透剂与葡萄糖(1.5%)相当。与其他中性pH溶液相比,用葡萄糖聚合物溶液(磷酸盐缓冲盐水中7.5%葡萄糖聚合物,pH 7.3)孵育导致细胞因子释放显著降低(LPS刺激:IL-1β,69±19 pg/mL)(P < 0.01)。这些结果表明,与乳酸相比,作为缓冲剂的碳酸氢盐在单核细胞因子释放和活力方面具有更好的生物相容性。在生理pH值下,氨基酸和葡萄糖在这些参数方面相当。然而,葡萄糖聚合物溶液与细胞因子释放的显著降低有关。